Cargando…
Apatinib-treated advanced medullary thyroid carcinoma: a case report
Medullary thyroid carcinoma (MTC) is a rare malignancy originating from calcitonin-producing parafollicular C cells of the thyroid. Neither radiotherapy nor chemotherapy has demonstrated durable objective responses in patients with advanced MTC. Vandetanib and cabozantinib are the 2 tyrosine kinase...
Autores principales: | Chen, Kan, Gao, Yun, Shi, Fei, Cao, Guangqiang, Bao, Jiandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783142/ https://www.ncbi.nlm.nih.gov/pubmed/29403290 http://dx.doi.org/10.2147/OTT.S142598 |
Ejemplares similares
-
Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review
por: Cai, Sina, et al.
Publicado: (2017) -
Metastatic medullary thyroid carcinoma: A case report
por: Niafar, Mitra, et al.
Publicado: (2011) -
Educational Case: Medullary Thyroid Carcinoma
por: McGary, Carl T.
Publicado: (2018) -
Oncocytic Variant of Medullary Thyroid Carcinoma - A Case Report
por: Parampalli Srinivas, Srilatha, et al.
Publicado: (2019) -
Hepatocellular carcinoma successfully treated with ALPPS and apatinib: A case report
por: Liu, Ling, et al.
Publicado: (2019)